Evidence map›Paper›PMID 23080358›Full record

Trial reportAIDS and behavior2013

High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.

Elisabeth Maria Van der Elst, Judie Mbogua, Don Operario, Gaudensia Mutua, Caroline Kuo, Peter Mugo, Jennifer Kanungi, Sagri Singh, Jessica Haberer, Frances Priddy and 1 more

Open access · greenAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 191 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed, 10 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

191 citing papers in PubMed, 10 syntheses or guidelines pooled it, 275 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Substance Use and HIV Risk Among Men Who Have Sex With Men in Africa: A Systematic Review.Journal of acquired immune deficiency syndromes (1999) · 2017
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Elisabeth Maria Van der ElstCentre for Geographic Medicine Research-Coast, Kenya Medical Research Institute, P.O. Box 230, Kilifi, Kenya. EvanderElst@kemri-wellcome.org
Judie Mbogua
Don Operario
Gaudensia Mutua
Caroline Kuo
Peter Mugo
Jennifer Kanungi
Sagri Singh
Jessica Haberer
Frances Priddy
Eduard Joachim Sanders
Kenya Medical Research Institute · KEInternational AIDS Vaccine Initiative · USKenya AIDS Vaccine Initiative · KECenter for Global Health · USJohn Brown University · USRhode Island Hospital · USUniversity of Oxford · GB

Funding

Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in UgandaK23MH087228 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2009 to 2013
$916k
NIMH NIH HHS K23 MH087228Wellcome Trust 092654
6 · The paper itself

Abstract

This paper used qualitative methods to explore experiences of men who have sex with men and female sex workers in Nairobi and Mtwapa, Kenya, who used oral pre-exposure prophylaxis (PrEP) for HIV prevention as part of a four-month trial of safety, acceptability and adherence. Fifty-one of 72 volunteers who took part in a randomized, placebo-controlled, blinded trial that compared daily and intermittent dosage of PrEP underwent qualitative assessments after completing the trial. Analyses identified three themes: (i) acceptability of PrEP was high, i.e. side effects were experienced early in the study but diminished over time, however characteristics of pills could improve comfort and use; (ii) social impacts such as stigma, rumors, and relationship difficulties due to being perceived as HIV positive were prevalent; (iii) adherence was challenged by complexities of daily life, in particular post-coital dosing adherence suffered from alcohol use around time of sex, mobile populations, and transactional sex work. These themes resonated across dosing regimens and gender, and while most participants favored the intermittent dosing schedule, those in the intermittent group noted particular challenges in adhering to the post-coital dose. Culturally appropriate and consistent counseling addressing these issues may be critical for PrEP effectiveness.

Indexed as

Drug MonitoringAdolescentAdultAnti-HIV AgentsDeoxycytidineDrug CombinationsEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationFemaleHIV InfectionsHomosexuality, MaleHumansKenyaMaleMedication AdherenceMiddle AgedOrganophosphorus CompoundsAnti-HIV AgentsDeoxycytidineDrug CombinationsEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationOrganophosphorus Compounds

Identifiers

PMID23080358
PMCPMC3690654
OpenAlexW1996849719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.